Boston, Massachusetts, United States Lineage Capital appeared to be the VC, which was created in 2003. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Boston.
The fund is generally included in less than 2 deals every year. Deals in the range of 5 - 10 millions dollars are the general things for fund. The high activity for fund was in 2018.
The overall number of key employees were 4.
Among the most popular portfolio startups of the fund, we may highlight Visible Body. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Machinery Manufacturing, Software. Besides, a startup needs to be aged more than 20 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are Capitala Group, Abacus Finance Group.
| Fund Name | Location |
| Armada Ventures | England, London, United Kingdom |
| Biederstein-Beteiligungen | - |
| Chimera Partners | England, London, United Kingdom |
| Elysium Venture Capital | California, Palo Alto, United States |
| ESOP | - |
| InterBiz | Japan, Tokyo |
| KICK Ventures | Brazil, São Paulo, Sao Paulo |
| KSR Ventures | - |
| Medison Ventures | HaMerkaz, Israel, Petah Tiqva |
| SURGE Accelerator | Houston, Texas, United States |
| Techstars Risingstars | - |
| United States Special Operations Command | Florida, Tampa, United States |
| Updater | New York, New York, United States |
| Venture Technologies | Mississippi, Ridgeland, United States |
| W Ventures | Dortmund, Germany, Nordrhein-Westfalen |
| W Ventures | Baltimore, Maryland, United States |
| Winbond Electronics | Taichung, Taiwan |
| Zhuopu Capital | Beijing, China, Haidian |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
BioIVT | 01 Mar 2010 | New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
BioIVT | 01 Mar 2010 | New York, United States |
